Cold Sore Treatment Docosanol Cream
Product Images NDC 10157-2124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cold Sore Treatment Docosanol (NDC 10157-2124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blistex Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (2 g Tube Blister Pack)

Principal Display Panel (2 g Tube Blister Pack)
This text appears to be a description for a Dermatologist recommended cold sore treatment - Docosanol Cream 10%. The cream is FDA approved to shorten healing time and duration of symptoms. It is meant for topical use only and should be applied to affected areas gently but completely. The cream can help alleviate symptoms such as tingling, pain, burning, and itching. Users are advised to use the product five times a day until healed and to avoid sharing it with others to prevent infection spread. In case of severe allergic reactions, users should stop using the product and seek medical help immediately. The cream contains active and inactive ingredients specified in the text. It is distributed by Blistex Inc. and made in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.